Recent News

• 11.10.2025 - Allogene Therapeutics Announces Participation in Upcoming Investor Conferences
• 11.06.2025 - Allogene Therapeutics Reports Third Quarter 2025 Financial Results and Business Update
• 11.03.2025 - Allogene Therapeutics Announces ALPHA3 Trial-in-Progress Poster Presentation at ASH Annual Meeting
• 10.30.2025 - Allogene Therapeutics to Report Third Quarter 2025 Financial Results and Provide Business Update
• 10.14.2025 - 8-K: Report of unscheduled material events or corporate event
• 10.02.2025 - Citi's SMID call series
• 09.19.2025 - Citi’s SMID call series
• 09.03.2025 - Citi's 2025 Biopharma Back to School Conference
• 08.29.2025 - Citi’s 2025 Biopharma Back to School Conference
• 08.27.2025 - Allogene Therapeutics Announces Participation in Upcoming Investor Conference

Recent Filings

• 11.06.2025 - 8-K Current report
• 11.06.2025 - 10-Q Quarterly report [Sections 13 or 15(d)]
• 11.06.2025 - EX-99.1 EX-99.1
• 10.23.2025 - 4 Statement of changes in beneficial ownership of securities
• 10.21.2025 - 144 Report of proposed sale of securities
• 10.14.2025 - 8-K Current report